Dr. Sarah G. Finnegan, MD

Dr. Finnegan practices at Kaleida Health in Buffalo, New York.

Dr. Finnegan's NPI, 1043288426, was assigned on March 10, 2006. Dr. Finnegan graduated from Jacobs School of Medicine and Biomedical Sciences in 1994. Dr. Finnegan holds New York license 201204.

Dr. Finnegan's primary practice is Kaleida Health, at 818 Ellicott St, Buffalo, NY 14203 in Erie County. The practice phone is (716) 323-2000.

Dr. Finnegan's primary practice is Kaleida Health in Buffalo, New York. Dr. Finnegan is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Kaleida Health. Dmand AI also links Dr. Finnegan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finnegan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Finnegan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Finnegan is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Finnegan is licensed in New York.

Dmand AI lists epilepsy and seizures among the conditions Dr. Finnegan treats.

CMS data shows 101 Medicare services from Dr. Finnegan across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $8,229 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Finnegan in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Finnegan's median patient age at 15, with 46% women.

In 2024, Dr. Finnegan wrote 110 Medicare Part D claims for 18 patients. 89% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $1,796 in total drug cost. In 2023, CMS named 199 claims across 8 drugs.

Dr. Finnegan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Finnegan, published from 2001 to 2017. Dr. Finnegan's most frequent co-authors are Bushra Afzal, MD, Naeem Mahfooz, MD and Mariam Noor, MD.

CMS Open Payments shows 40 general payments to Dr. Finnegan from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. LivaNova USA, Inc. paid the most, $359.

Dr. Finnegan graduated from Jacobs School of Medicine and Biomedical Sciences in 1994.

Dr. Finnegan is in network with 18 carriers, including Aetna, MVP Health Care and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.